To confirm the increased expression of PYK2 in HER2+/ER−/PR- breast cancer cells following metformin treatment, immunoblotting experiments were performed with PYK2 antibody and using whole cell extracts from SkBr3 and MDA-MB-453 breast cancer cell lines. Here, PTK2B is linked to breast carcinoma.